Many patients with liver failure will die while awaiting transplantation. A Bioartificial Liver Assist System (BAL), a device using porcine hepatocytes, has been developed. During the past year the safety of BAL has been established, leading to the design of an FDA-approved, industry supported multicenter clinical trial which will begin in early 1996 to determine the efficacy of BAL in patients awaiting liver transplantation.
Showing the most recent 10 out of 1232 publications